--- title: "HALEON UK IP LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e json: https://whiteintel.dev/api/public/dossier/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e identifier: oo:GB-COH-09237645 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # HALEON UK IP LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-09237645` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e ## Cross-source identity The same real-world entity, resolved across sources: - **HALEON UK IP LIMITED** — GLEIF · `lei:213800XJGPRTTF6VV906` — https://whiteintel.dev/entity/22d5dc1d-f6e2-5125-9c1d-dbc869392f93 ## Ownership & control ### Owners / controllers - **HALEON UK HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137 - **HALEON UK ENTERPRISES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/adc36846-5bce-5ef8-964b-f38192f2a72e - **HALEON UK HOLDINGS (NO.3) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/d15b7551-f682-5c8c-8bbb-508f2e15ec56 - **CONSUMER HEALTHCARE HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/d004db38-26a0-5e2f-8317-b56a956d6acb - **GSK CONSUMER HEALTHCARE HOLDINGS (NO.5) LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/47c0c4fe-26e9-5bbe-9930-fb8fff9c3bb9 - **CONSUMER HEALTHCARE HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d004db38-26a0-5e2f-8317-b56a956d6acb - **HALEON UK ENTERPRISES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/adc36846-5bce-5ef8-964b-f38192f2a72e - **HALEON UK HOLDINGS (NO.3) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/d15b7551-f682-5c8c-8bbb-508f2e15ec56 - **GSK CONSUMER HEALTHCARE HOLDINGS (NO.5) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/47c0c4fe-26e9-5bbe-9930-fb8fff9c3bb9 - **Glaxosmithkline Consumer Healthcare Holdings Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/84ddff00-3c64-4b50-ae4b-d1ba198ec5a8 ### UBO chain (walk to the ultimate owner) A **112-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `09237645` - **Status:** active - **Type:** ltd - **Incorporated:** 2014-09-26 - **Registered office:** Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY, England - **SIC:** 64209 ### Officers - [HALEON UK CORPORATE SECRETARY LIMITED](https://whiteintel.dev/entity/4c06b7f0-3494-5cca-b8a0-ef07bd339a85) — corporate secretary · appointed 2022-04-06 - BECK, Gemma Louise — director · British · appointed 2022-03-04 - EL ANSARI, Khalid — director · British · appointed 2022-03-04 - [HALEON UK CORPORATE DIRECTOR LIMITED](https://whiteintel.dev/entity/231d146c-46f2-5ffb-80c7-3e2fcb69af60) — corporate director · appointed 2022-04-06 - [HALEON UK CORPORATE SECRETARY LIMITED](https://whiteintel.dev/entity/4c06b7f0-3494-5cca-b8a0-ef07bd339a85) — corporate director · appointed 2022-04-06 - [EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED](https://whiteintel.dev/entity/4401174d-4f25-5698-8e3a-3f933dd54455) — corporate secretary · appointed 2014-09-26 · resigned 2022-04-06 - ARISTIDOU, Antrinkos Andrew — director · British · appointed 2019-08-19 · resigned 2020-07-31 - BLACKBURN, Paul Frederick — director · British · appointed 2014-09-26 · resigned 2016-03-01 - BOX, Jonathan Wilson — director · British · appointed 2016-06-17 · resigned 2017-11-30 - COOPER, Nicholas Ian — director · British · appointed 2019-09-11 · resigned 2022-03-04 - FOSTER-HAWES, Melanie — director · British · appointed 2016-06-17 · resigned 2019-01-15 - GODINO ESCOLAR, Mariano Jesus — director · British · appointed 2021-05-27 · resigned 2022-03-04 - GREEN, Richard — director · British · appointed 2019-01-15 · resigned 2020-03-10 - HESTLER, Tobias Hannes — director · German,Swiss · appointed 2017-11-30 · resigned 2020-03-10 - MEHTA, Jai — director · British · appointed 2020-07-31 · resigned 2021-05-26 - WALKER, Adam — director · British · appointed 2015-06-03 · resigned 2016-08-01 - [GLAXO GROUP LIMITED](https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8) — corporate director · appointed 2014-09-26 · resigned 2022-04-06 - [THE WELLCOME FOUNDATION LIMITED](https://whiteintel.dev/entity/28855862-898c-512b-ab1c-45a367bd933a) — corporate director · appointed 2014-09-26 · resigned 2022-04-06 ### Beneficial owners (Persons with Significant Control) - [Haleon Uk Holdings (No.3) Limited](https://whiteintel.dev/entity/d15b7551-f682-5c8c-8bbb-508f2e15ec56) — 75–100% shares · corporate PSC · England — since 2021-09-01 - [Gsk Consumer Healthcare Holdings (No.5) Limited](https://whiteintel.dev/entity/47c0c4fe-26e9-5bbe-9930-fb8fff9c3bb9) — 75–100% shares · corporate PSC · England — ceased 2021-09-01 - [Prism Pch Limited](https://whiteintel.dev/entity/adc36846-5bce-5ef8-964b-f38192f2a72e) — 75–100% shares · corporate PSC · England — ceased 2021-06-28 - [Consumer Healthcare Holdings Limited](https://whiteintel.dev/entity/d004db38-26a0-5e2f-8317-b56a956d6acb) — 75–100% shares · corporate PSC · United Kingdom — ceased 2019-12-13 - [Glaxosmithkline Consumer Healthcare Holdings Limited](https://whiteintel.dev/entity/84ddff00-3c64-4b50-ae4b-d1ba198ec5a8) — 75–100% shares · corporate PSC · England — ceased 2019-07-02 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09237645 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09237645 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **HALEON UK IP LIMITED** — https://whiteintel.dev/entity/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **HALEON UK IP LIMITED**. Human view: https://whiteintel.dev/entity/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e · Structured JSON: https://whiteintel.dev/api/public/dossier/7b0ec468-ef40-5ff9-9b0b-eda0e679f24e._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._